Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Acanthosis nigricans in adolescents: a practical approach.

De Sanctis V, Soliman A, Marsciani A, Timoncini G, Reggiani L, Zucchini A, Altieri E.

Georgian Med News. 2013 Sep;(222):73-8. Review.

PMID:
24099818
2.

Acanthosis nigricans.

Stuart CA, Driscoll MS, Lundquist KF, Gilkison CR, Shaheb S, Smith MM.

J Basic Clin Physiol Pharmacol. 1998;9(2-4):407-18. Review.

PMID:
10212845
3.

Acanthosis nigricans: A fold (intertriginous) dermatosis.

Kutlubay Z, Engin B, Bairamov O, Tüzün Y.

Clin Dermatol. 2015 Jul-Aug;33(4):466-70. doi: 10.1016/j.clindermatol.2015.04.010. Review.

PMID:
26051063
4.

Acanthosis nigricans: a practical approach to evaluation and management.

Higgins SP, Freemark M, Prose NS.

Dermatol Online J. 2008 Sep 15;14(9):2. Review.

5.

Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices.

Kong AS, Williams RL, Smith M, Sussman AL, Skipper B, Hsi AC, Rhyne RL; RIOS Net Clinicians..

Ann Fam Med. 2007 May-Jun;5(3):202-8.

6.

Juvenile acanthosis nigricans and insulin resistance.

Hermanns-Lê T, Hermanns JF, Piérard GE.

Pediatr Dermatol. 2002 Jan-Feb;19(1):12-4.

PMID:
11860562
7.

Juvenile acanthosis nigricans.

Sinha S, Schwartz RA.

J Am Acad Dermatol. 2007 Sep;57(3):502-8. Review.

PMID:
17592743
8.

Assessment of patients with acanthosis nigricans skin lesion for hyperinsulinemia, insulin resistance and diabetes risk.

Gilkison C, Stuart CA.

Nurse Pract. 1992 Feb;17(2):26, 28, 37 passim. Review.

PMID:
1542462
9.

Acanthosis nigricans associated with insulin resistance : pathophysiology and management.

Hermanns-Lê T, Scheen A, Piérard GE.

Am J Clin Dermatol. 2004;5(3):199-203. Review.

PMID:
15186199
10.

Acanthosis nigricans as a local cutaneous side effect of repeated human insulin injections.

Buzási K, Sápi Z, Jermendy G.

Diabetes Res Clin Pract. 2011 Nov;94(2):e34-6. doi: 10.1016/j.diabres.2011.07.023.

PMID:
21839533
11.

Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes in obese children and adolescents? A systematic review.

Abraham C, Rozmus CL.

J Sch Nurs. 2012 Jun;28(3):195-205. doi: 10.1177/1059840511430952. Review.

PMID:
22179051
12.

Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes.

Litonjua P, Piñero-Piloña A, Aviles-Santa L, Raskin P.

Endocr Pract. 2004 Mar-Apr;10(2):101-6.

PMID:
15256325
13.

Prevalence of acanthosis nigricans in an unselected population.

Stuart CA, Pate CJ, Peters EJ.

Am J Med. 1989 Sep;87(3):269-72.

PMID:
2773965
14.

Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus.

Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M.

Clin Pediatr (Phila). 1998 Feb;37(2):73-9.

PMID:
9492114
15.
16.

Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk.

Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM.

Am J Public Health. 1994 Nov;84(11):1839-42.

17.

Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents.

Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW.

J Adolesc Health. 2001 May;28(5):372-6.

PMID:
11336866
18.

Antibodies against the insulin receptor in paraneoplastic acanthosis nigricans.

Matsuoka LY, Goldman J, Wortsman J, Kleinsmith D, Kupchella CE.

Am J Med. 1987 Jun;82(6):1253-6.

PMID:
3605142
19.

Spectrum of endocrine abnormalities associated with acanthosis nigricans.

Matsuoka LY, Wortsman J, Gavin JR, Goldman J.

Am J Med. 1987 Oct;83(4):719-25.

PMID:
3674058
20.
Items per page

Supplemental Content

Support Center